Author:
Moise Pamela A.,Culshaw Darren L.,Wong-Beringer Annie,Bensman Joyce,Lamp Kenneth C.,Smith Winter J.,Bauer Karri,Goff Debra A.,Adamson Robert,Leuthner Kimberly,Virata Michael D.,McKinnell James A.,Chaudhry Saira B.,Eskandarian Romic,Lodise Thomas,Reyes Katherine,Zervos Marcus J.
Subject
Pharmacology (medical),Pharmacology
Reference24 articles.
1. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia;Sakoulas;J Clin Microbiol,2004
2. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity;Hidayat;Arch Intern Med,2006
3. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia;Soriano;Clin Infect Dis,2008
4. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin;Lodise;Antimicrob Agents Chemother,2008
5. Moise PA, Culshaw DL, Wong-Beringer A, et al. 2013. Patterns of antibiotic utilization for MRSA bloodstream infections with vancomycin MIC 1.5-2.0 mg/L: a multi-center evaluation, Abstr. 1733. IDWeek 2013, San Francisco, CA.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献